Website: N/A
Stock Symbol: NASDAQ: SGMO
Market Value: N/A (in millions)
We are a leader in the research, development and commercialization of zinc
finger DNA-binding proteins (ZFPs), a naturally occurring class of proteins, and
have used our knowledge and expertise to develop a proprietary technology
platform. ZFPs can be engineered (see Fig. 1) to make ZFP transcription factors,
or ZFP TFs ™, proteins that can be used to turn genes on or off, and ZFP
nucleases, ZFNsTM, proteins that enable us to modify DNA sequences in a variety
of ways. As ZFPs act at the DNA level, they have broad potential applications in
several areas including human therapeutics, plant agriculture, research reagents
and cell-line engineering.
The main focus for our company is the development of novel human therapeutics
and we are building a pipeline of ZFP Therapeutics™.